1. Home
  2. IMRN vs ARTW Comparison

IMRN vs ARTW Comparison

Compare IMRN & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuron Limited

IMRN

Immuron Limited

HOLD

Current Price

$0.86

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Logo Art's-Way Manufacturing Co. Inc.

ARTW

Art's-Way Manufacturing Co. Inc.

HOLD

Current Price

$2.37

Market Cap

11.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMRN
ARTW
Founded
1994
1956
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
11.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IMRN
ARTW
Price
$0.86
$2.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3M
27.0K
Earning Date
02-27-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.49
Revenue
$4,777,422.00
$24,079,949.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$6.10
Revenue Growth
48.63
N/A
52 Week Low
$0.88
$1.43
52 Week High
$2.48
$4.71

Technical Indicators

Market Signals
Indicator
IMRN
ARTW
Relative Strength Index (RSI) 23.24 52.47
Support Level $0.87 $2.18
Resistance Level $0.95 $2.42
Average True Range (ATR) 0.06 0.13
MACD -0.01 0.01
Stochastic Oscillator 2.57 51.35

Price Performance

Historical Comparison
IMRN
ARTW

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

Share on Social Networks: